Melissa K. Osborn, MD
Assistant Professor
Division of Infectious Diseases
Emory University School of Medicine
Atlanta, GA

Email: mkosbor "at" emory.edu

Research Topics

• Antiretrovirals and hepatitis C virus (HCV) infection
• Predicting HCV response to interferon alfa therapy
  
  
  

Lecture and Writing Topics

• HIV and HCV and hepatitis B virus (HBV) coinfections
• New therapies for HCV infections
  
  
  

Current Professional Summary

Dr Osborn is an attending physician at Emory University School of Medicine.  She specializes in HIV and viral hepatitis coinfection, and provides clinical care for HIV monoinfected patients and general infectious diseases patients.  She also works with Hemophilia of Georgia to care for patients infected with HIV or HCV via contaminated factor.  In addition to clinical duties, she is completing a Masters of Science in Clinical Research and will be involved in clinical trials for HIV/HCV coinfected patients.  Current research is being carried out in conjunction with the Emory Vaccine Center, examining immune correlates of HCV persistence versus clearance, as well as correlates of interferon alfa response.


Committees and Organizations

• Member, Hepatitis C Working Group of Georgia
• Member, Hepatitis Clinical Management Group, Georgia Department of Human Resources
• Member, Infectious Diseases Society of America/HIV Medicine Association
• Member, American Association for the Study of Liver Diseases
  
  

Honors and Awards

• Emory University School of Medicine Fellow's Teaching Award (2004-2005)
• Conference on Retroviruses and Opportunistic Infections Young Investigator Award (2006)
  
  

Education

• BS in Biology, Mount Union College (1995)
• MD in Medicine, Ohio State University (1999)
• MS in Clinical Research, Emory University, (expected 2008)
• Residency in Internal Medicine, Emory University School of Medicine (1999-2002)
• Fellowship in Infectious Diseases, Emory University School of Medicine (2003-2006)
  
  
  

Selected Publications

1. Osborn MK, Guest JL, Rimland D.  Hepatitis B and HIV coinfection: relationship of different serologic patterns to survival and liver disease. HIV Medicine. 2007; 8:271-279.
2. Osborn MK, Regev A, Han S, et al.  Outcomes of patients with hepatitis B who develop viral breakthrough or genotypic resistance to antiviral therapy while on the liver transplant waiting list. 2007. In Press.
3. Osborn MK, Lok ASF. Antiviral options for the treatment of chronic hepatitis B. Journal of Antimicrobial Chemotherapy. 2006; 57:1030-1034
4. Osborn MK, Steinberg JP.  Subdural empyema and other suppurative complications of paranasal sinusitis.  Lancet Infect Dis. 2007; 7:62-87.